These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3278434

  • 1. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
    Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ.
    Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
    [Abstract] [Full Text] [Related]

  • 2. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M, Durrbach A, Hiesse C, Ladouceur M, Benoit G, Charpentier B.
    Transplantation; 2008 Dec 27; 86(12):1732-7. PubMed ID: 19104413
    [Abstract] [Full Text] [Related]

  • 3. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M, Szepietowski T, Szewczyk Z, Szydłowski Z.
    Arch Immunol Ther Exp (Warsz); 1992 Dec 27; 40(2):163-8. PubMed ID: 1299176
    [Abstract] [Full Text] [Related]

  • 4. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov 27; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 5. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
    Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC.
    Transplantation; 1988 Aug 27; 46(2):223-8. PubMed ID: 3043779
    [Abstract] [Full Text] [Related]

  • 6. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Aug 27; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 7. Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients.
    Boratyńska M, Banasik M, Patrzalek D, Szyber P, Klinger M.
    Transplant Proc; 2005 Mar 27; 37(2):839-42. PubMed ID: 15848550
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun 27; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 9. Effect of initial slow graft function on renal allograft rejection and survival.
    Humar A, Johnson EM, Payne WD, Wrenshall L, Sutherland DE, Najarian JS, Gillingham KJ, Matas AJ.
    Clin Transplant; 1997 Dec 27; 11(6):623-7. PubMed ID: 9408697
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients.
    Michael HJ, Francos GC, Burke JF, Besarab A, Moritz M, Gillum D, Jarrell B.
    Transplantation; 1989 Nov 27; 48(5):805-8. PubMed ID: 2683263
    [Abstract] [Full Text] [Related]

  • 11. Timing of cyclosporine administration in patients with delayed graft function.
    Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ.
    J Surg Res; 1987 Dec 27; 43(6):489-94. PubMed ID: 3320528
    [Abstract] [Full Text] [Related]

  • 12. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts.
    Menkis AH, Powell AM, Novick RJ, McKenzie FN, Kostuk WJ, Pflugfelder PW, Brown JE, Rochon J, Chow LH, Stiller C.
    J Heart Lung Transplant; 1992 Dec 27; 11(3 Pt 1):569-76. PubMed ID: 1610866
    [Abstract] [Full Text] [Related]

  • 13. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
    Slakey DP, Johnson CP, Callaluce RD, Browne BJ, Zhu YR, Roza AM, Adams MB.
    Transplantation; 1993 Oct 27; 56(4):827-31. PubMed ID: 8212201
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for delayed kidney function and impact of delayed function on patient and graft survival in adult graft recipients.
    Pieringer H, Biesenbach G.
    Clin Transplant; 2005 Jun 27; 19(3):391-8. PubMed ID: 15877804
    [Abstract] [Full Text] [Related]

  • 15. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
    Indudhara R, Novick AC, Hodge E, Goormastic M, Papajcik D, Mastroianni B, Cook D.
    Urology; 1996 Jun 27; 47(6):807-12. PubMed ID: 8677568
    [Abstract] [Full Text] [Related]

  • 16. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience.
    Malinow L, Walker J, Klassen D, Oldach D, Schweitzer E, Bartlett ST, Weir MR.
    Clin Transplant; 1996 Jun 27; 10(3):237-42. PubMed ID: 8826659
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb 27; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 18. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM, Wright CE, Bowers VD, Heinrichs DF, Shires DL.
    Clin Transpl; 1999 Feb 27; ():149-58. PubMed ID: 11038633
    [Abstract] [Full Text] [Related]

  • 19. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
    Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DE, Simmons RL, Najarian JS.
    Transplantation; 1986 Feb 27; 41(2):177-81. PubMed ID: 3511581
    [Abstract] [Full Text] [Related]

  • 20. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE, Ackman CF, Horowitz I.
    Can Med Assoc J; 1976 Dec 18; 115(12):1205-8. PubMed ID: 793705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.